Related Experiment Video
Updated: Jun 19, 2026

In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus
Published on: December 2, 2012
Serial Imaging of Virus-Associated Necrotizing Disseminated Acute Leukoencephalopathy (VANDAL) in COVID-19
Insights
Critically ill COVID-19 patients can develop acute disseminated leukoencephalopathy. This condition progresses to brain atrophy and cystic lesions, often leading to poor outcomes and mortality.
Area of Science:
- Neurology
- Infectious Diseases
- Radiology
Background:
- Coronavirus disease 2019 (COVID-19) is associated with various neurological complications, including leukoencephalopathy.
- Acute disseminated leukoencephalopathy has been observed in critically ill COVID-19 patients.
Purpose of the Study:
- To describe the clinical and imaging features of acute disseminated leukoencephalopathy in critically ill COVID-19 patients.
- To document the short-term imaging evolution of these neurological changes.
Main Methods:
- Retrospective review of clinical data, laboratory results, and imaging findings.
- Analysis of outcomes for 8 critically ill patients with COVID-19 and acute disseminated leukoencephalopathy.
Main Results:
- All patients showed white matter changes, predominantly in posterior regions.
- Follow-up imaging revealed brain atrophy and evolution of lesions into necrotizing cystic cavitations.
- Patients exhibited inflammatory markers, prolonged ventilator support, poor functional outcomes, and significant mortality.
Conclusions:
- Critically ill COVID-19 patients can develop acute disseminated leukoencephalopathy with rapid evolution to cystic degeneration and brain atrophy.
- This entity, termed virus-associated necrotizing disseminated acute leukoencephalopathy, may stem from COVID-19-related endothelial injury, cytokine storm, or thrombotic microangiopathy.
Background And Purpose:
Various patterns of leukoencephalopathy have been described in coronavirus disease 2019 (COVID-19). In this article, we aimed to describe the clinical and imaging features of acute disseminated leukoencephalopathy in critically ill patients with COVID-19 and the imaging evolution during a short-term follow-up.
Materials And Methods:
We identified and reviewed the clinical data, laboratory results, imaging findings, and outcomes for 8 critically ill patients with COVID-19 with acute disseminated leukoencephalopathy.
Results:
All patients demonstrated multiple areas of white matter changes in both cerebral hemispheres; 87.5% (7/8) of patients had a posterior predilection. Four patients (50%) had short-term follow-up imaging within a median of 17 days after the first MR imaging; they developed brain atrophy, and their white matter lesions evolved into necrotizing cystic cavitations. All (8/8) patients had inflammatory cytokine release syndrome as demonstrated by elevated interleukin-6, D-dimer, lactate dehydrogenase, erythrocyte sedimentation rate, C-reactive protein, and ferritin levels. Most (7/8; 87.5%) patients were on prolonged ventilator support (median, 44.5 days; interquartile range, 20.5 days). These patients had poor functional outcomes (6/8 [75%] patients were discharged with mRS 5) and high mortality (2/8, 25%).
Conclusions:
Critically ill patients with COVID-19 can develop acute disseminated leukoencephalopathy that evolves into cystic degeneration of white matter lesions with brain atrophy during a short period, which we dubbed virus-associated necrotizing disseminated acute leukoencephalopathy. This may be the result of COVID-19-related endothelial injury, cytokine storm, or thrombotic microangiopathy.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Cytomegalovirus Disease
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

